|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,276.40 INR | -3.83% |
|
+14.88% | -5.32% |
| 24/12 | Concord Biotech Limited Announces Resignation of Hina Patel as Company Secretary and Compliance Officer, Effective January 21, 2026 | CI |
| 18/12 | Concord Biotech Names CFO | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CONCORD BIOTECH LIMITED | Biopharmaceuticals | -3.83% | +14.88% | -5.32% | -43.00% | - | 153.26Cr |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- CONCORDBIO Stock
- Charts Concord Biotech Limited
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition